A Phase I Trial of Dasatinib, an SRC-Family Kinase Inhibitor, in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Recurrent Ovarian Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-0507
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)